Intact Financial Corporation (IFCZF)

Revance Therapeutics Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Premiums & Annuity Revenue	28,549	28,183	27,949	28,827	16,238	11,241
Total Interest & Dividend Income	415	520	358	1,525	706	577
Gain (Loss) on Sale of Investments	444	148	249	-285	630	-14
Other Revenue	79	89	96	103	310	681
Total Revenue	29,487	28,940	28,652	30,170	17,884	12,485
Revenue Growth (YoY)	-0.51%	1.00%	-5.03%	68.70%	43.24%	10.41%
Policy Benefits	20,084	19,746	19,983	20,044	8,967	6,883
Policy Acquisition & Underwriting Costs	5,573	5,440	5,168	4,833	5,611	3,696
Other Operating Expenses	378	690	1,116	2,037	413	346
Total Operating Expenses	26,035	25,876	26,267	26,914	14,991	10,925
Operating Income	3,452	3,064	2,385	3,256	2,893	1,560
Interest Expense	-223	-222	-229	-177	-153	-115
Currency Exchange Gain (Loss)	150	173	86	-137	9	10
Other Non Operating Income (Expenses)	71	132	72	13	-	-
EBT Excluding Unusual Items	3,450	3,147	2,314	2,955	2,749	1,455
Merger & Restructuring Charges	-400	-407	-517	-353	-464	-96
Gain (Loss) on Sale of Assets	-	138	-	405	-	-
Asset Writedown	-	-	-	-	79	-
Other Unusual Items	-	-	7	-	204	-
Pretax Income	3,050	2,878	1,804	3,007	2,568	1,359
Income Tax Expense	628	568	473	557	480	277
Earnings From Continuing Ops.	2,422	2,310	1,331	2,450	2,088	1,082
Minority Interest in Earnings	-5	-13	-15	4	-21	-
Net Income	2,417	2,297	1,316	2,454	2,067	1,082
Preferred Dividends & Other Adjustments	90	90	84	60	53	52
Net Income to Common	2,327	2,207	1,232	2,394	2,014	1,030
Net Income Growth	14.55%	74.54%	-46.37%	18.72%	91.03%	43.50%
Shares Outstanding (Basic)	178	178	176	176	162	143
Shares Outstanding (Diluted)	179	179	176	176	162	143
Shares Change (YoY)	0.48%	1.36%	0.34%	8.13%	13.57%	2.51%
EPS (Basic)	13.05	12.38	6.99	13.63	12.40	7.20
EPS (Diluted)	13.03	12.36	6.99	13.63	12.40	7.20
EPS Growth	14.66%	76.82%	-48.73%	9.93%	72.18%	41.72%
Free Cash Flow	3,510	2,958	1,388	3,254	2,819	2,189
Free Cash Flow Per Share	19.64	16.56	7.88	18.53	17.36	15.31
Dividend Per Share	5.080	4.840	4.400	4.000	3.400	3.320
Dividend Growth	9.96%	10.00%	10.00%	17.65%	2.41%	9.21%
Operating Margin	11.71%	10.59%	8.32%	10.79%	16.18%	12.50%
Profit Margin	7.89%	7.63%	4.30%	7.94%	11.26%	8.25%
Free Cash Flow Margin	11.90%	10.22%	4.84%	10.79%	15.76%	17.53%
EBITDA	3,941	3,512	2,795	3,665	3,222	1,809
EBITDA Margin	13.36%	12.13%	9.75%	12.15%	18.02%	14.49%
D&A For EBITDA	489	448	410	409	329	249
EBIT	3,452	3,064	2,385	3,256	2,893	1,560
EBIT Margin	11.71%	10.59%	8.32%	10.79%	16.18%	12.50%
Effective Tax Rate	20.59%	19.74%	26.22%	18.52%	18.69%	20.38%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.